Gloria Kayani
Overview
Explore the profile of Gloria Kayani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
Cheng C, Lian T, Zhu X, Virdone S, Sun K, Camm J, et al.
Open Heart
. 2025 Feb;
12(1).
PMID: 39914996
Background: Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial fibrillation (AF) have been sparsely investigated. Objective: To provide a contemporary prospective comparison...
2.
Aggarwal R, Ruff C, Virdone S, Perreault S, Kakkar A, Palazzolo M, et al.
Circulation
. 2024 Apr;
149(16):e1111-e1112.
PMID: 38620083
No abstract available.
3.
Prandoni P, Haas S, Fluharty M, Schellong S, Goto S, MacCallum P, et al.
Thromb Res
. 2024 Feb;
235:75-78.
PMID: 38308881
No abstract available.
4.
Chen A, Rao A, Oropallo A, Goldhaber S, Fluharty M, Maheshwari U, et al.
Thromb Res
. 2023 Nov;
232:123-132.
PMID: 37976732
Background: Economically developed countries continue to find that venous thromboembolism (VTE) is a major cause of morbidity and mortality. Objective: To compare baseline risk profiles and patient workflow patterns between...
5.
Prandoni P, Haas S, Fluharty M, Schellong S, Gibbs H, Tse E, et al.
J Thromb Thrombolysis
. 2023 Nov;
57(2):312-321.
PMID: 37932591
Although substantial progress has been made in the pathophysiology and management of the post-thrombotic syndrome (PTS), several aspects still need clarification. Among them, the incidence and severity of PTS in...
6.
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry
Goldhaber S, Bassand J, Camm A, Virdone S, Pieper K, Cools F, et al.
Am J Med
. 2023 Nov;
137(2):128-136.e13.
PMID: 37918777
Background: Oral anticoagulants (OAC) are underutilized in older patients with atrial fibrillation, despite proven clinical benefits. Our objective was to investigate baseline characteristics, treatment patterns, and impact of anticoagulation upon...
7.
Verheugt F, Fox K, Virdone S, Ambrosio G, Gersh B, Haas S, et al.
Am J Med
. 2023 Sep;
136(12):1187-1195.e15.
PMID: 37704071
Background: Many patients with atrial fibrillation suffer from comorbid vascular disease. The comparative efficacy and safety of different types of oral anticoagulation (OAC) in this patient group have not been...
8.
Barco S, Virdone S, Gotschi A, Ageno W, Arcelus J, Bingisser R, et al.
Thromb Res
. 2023 Aug;
230:27-32.
PMID: 37625200
Background: Antithrombotic treatment may improve the disease course in non-critically ill, symptomatic COVID-19 outpatients. Methods: We performed an individual patient-level analysis of the OVID and ETHIC randomized controlled trials, which...
9.
Aggarwal R, Ruff C, Virdone S, Perreault S, Kakkar A, Palazzolo M, et al.
Circulation
. 2023 Aug;
148(12):936-946.
PMID: 37621213
Background: Current clinical decision tools for assessing bleeding risk in individuals with atrial fibrillation (AF) have limited performance and were developed for individuals treated with warfarin. This study develops and...
10.
Lim T, Camm A, Virdone S, Singer D, Bassand J, Fonarow G, et al.
Clin Cardiol
. 2023 Aug;
46(11):1398-1407.
PMID: 37596725
Background: An unmet need exists to reliably predict the risk of intracranial hemorrhage (ICH) in patients with atrial fibrillation (AF) treated with oral anticoagulants (OACs). Hypothesis: An externally validated model...